Ohcanbohtosat - "pneumococcal conjugate vaccine"

Antibody persistence after pneumococcal conjugate vaccination in patients with chronic lymphocytic leukemia Dahkki Vesa Lindström, Janne Aittoniemi, Urpu Salmenniemi, Helena Käyhty, Heini Huhtala, Maija Itälä-Remes, Marjatta Sinisalo

Connect to this object online.

Impact of pneumococcal conjugate vaccines for children in high- and non-high-income countries Dahkki Robert Cohen, Jérémie François Cohen, Martin Chalumeau, Corinne Levy

Connect to this object online.

Safety and immunogenicity of 15-valent pneumococcal conjugate vaccine compared to 13-valent pneumococcal conjugate vaccine in adults ≥65 years of age previously vaccinated with 23-valent pneumococcal polysaccharide vaccine Dahkki James T. Peterson, Helen L. Stacey, John E. MacNair, Jianing Li, Jonathan S. Hartzel, Tina M. Sterling, Patrice Benner, Gretchen M. Tamms, Luwy K. Musey

Connect to this object online.

Understanding healthcare providers' preferred attributes of pediatric pneumococcal conjugate vaccines in the United States Dahkki Salini Mohanty, Jui-Hua Tsai, Ning Ning, Ana Martinez, Rishi P. Verma, Marieke Heisen, Jessica Weaver, Kristen A. Feemster, Bianca Chun, Thomas W. Weiss, Jordana K Schmier

Connect to this object online.

Cost-effectiveness of new pneumococcal conjugate vaccines in Turkey: a decision analytical model Dahkki Bakır Mustafa, Türel Özden, Topachevskyi Oleksandr

Connect to this object online.

Development strategy and lessons learned for a 10-valent pneumococcal conjugate vaccine (PNEUMOSIL®) Dahkki Mark R. Alderson, Vistasp Sethna, Lauren C. Newhouse, Steve Lamola, Rajeev Dhere

Connect to this object online.

Childhood meningitis in Kuwait in the era of post pneumococcal conjugate vaccination: A multicenter study Dahkki Hussain Sadeq, Entesar H. Husain, Amna Alkoot, Suha Atyani, Abdullah Al-fraij, Abdulrahman Al-Daithan, Talal AlSaleem, Anfal Taher, May Alenezi

Connect to this object online.

Cost-effectiveness of use of 20-valent pneumococcal conjugate vaccine among adults in Germany Dahkki Felicitas Kühne, Katharina Achtert, Franziska Püschner, Dominika Urbanski-Rini, Juliane Schiller, Ernestine Mahar, Josephine Friedrich, Mark Atwood, Ralf Sprenger, Jeffrey Vietri, Christof von Eiff, Christian Theilacker

Connect to this object online.

PHARMACOECONOMIC ASSESSMENT OF 13-VALENT PNEUMOCOCCAL CONJUGATE VACCINE IN IMMUNIZATION OF CHILDREN IN RUSSIAN FEDERATION Dahkki ​A. V. Rudakova, A. A. Baranov, Yu. V. Lobzin, N. I. Briko, L. S. Namazova-Baranova, V. K. Tatochenko, S. M. Kharit, S. V. Sidorenko, I. S. Koroleva, R. S. Kozlov, N. A. Mayanskii, M. P. Kostinov, N. F. Snegova

Connect to this object online.

The Analysis of Scientific Data on the Efficacy of Pneumococcal Conjugated Vaccine in the Cohort of Children with Bronchial Asthma Dahkki Tatiana A. Kaliuzhnaia, Marina V. Fedoseenko, Leyla S. Namazova-Baranova, Firuza Ch. Shakhtakhtinskaya, Arevaluis M. Selvyan, Svetlana V. Tolstova, Tatiana E. Privalova

Connect to this object online.

Pneumococcal conjugate vaccine use for the prevention of pneumococcal disease in adults <50 years of age Dahkki Raul E. Isturiz, Cassandra Hall-Murray, John M. McLaughlin, Vincenza Snow, Beate Schmoele-Thoma, Chris Webber, Allison Thompson, Daniel A Scott

Connect to this object online.

Safety profile of pneumococcal conjugate vaccines: systematic review of pre- and post-licensure data Dahkki Frank DeStefano, Dina Pfeifer, Hanna Nohynek

Connect to this object online.

Decline in childhood respiratory-related mortality after the introduction of the pneumococcal conjugate vaccine in Morocco Dahkki Mark A. Fletcher, Hammam Haridy

Connect to this object online.

Surveillance of bacterial meningitis in an Angolan pediatric hospital after the introduction of pneumococcal conjugate vaccines Dahkki Suvi Urtti, Manuel L. Cruzeiro, Linda de Gouveia, Heikki Peltola, Anne von Gottberg, Moe H. Kyaw, Tuula Pelkonen

Connect to this object online.

Review of vaccine effectiveness assumptions used in economic evaluations of infant pneumococcal conjugate vaccine Dahkki Matt Wasserman, Heather L Sings, Dylan Jones, Sarah Pugh, Margaret Moffatt, Raymond Farkouh

Connect to this object online.

Multi-valent pneumococcal conjugate vaccine for global health: From problem to platform to production Dahkki Anup Datta, Kapil Kapre, Indah Andi-Lolo, Subhash Kapre

Connect to this object online.

Accelerating Pneumococcal Conjugate Vaccine introductions in Indonesia: key learnings from 2017 to 2022 Dahkki Anithasree Athiyaman, Putri Herliana, Atiek Anartati, Niken Widyastuti, Prima Yosephine, Gertrudis Tandy, Sherli Karolina

Connect to this object online.

Safety of the 15-valent pneumococcal conjugate vaccine: A phase I clinical trial Dahkki Lu-Lu Pan, Zhao Gao, Wei-Wei Zhou, Min-Jie Li, Wen-Jian Fang, Wen-Juan Ji, Ying Zhao, Lin Du, Yu-Liang Zhao

Connect to this object online.

Cost-effectiveness analysis of routine 13-valent pneumococcal conjugate vaccinations in Chinese infants Dahkki Hua Zhou, Jinchun He, Bin Wu, Datian Che

Connect to this object online.

Decline in childhood respiratory-related mortality after the introduction of the pneumococcal conjugate vaccine in Morocco Dahkki Nada Bennani Mechita, Majdouline Obtel, Abdelilah Elmarnissi, Laila Lahlou, Aziza Lyaghfouri, Imad Cherkaoui, Mustapha Mrabet, Rachid Razine, Redouane Abouqal

Connect to this object online.